REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,483 | -64.1% | 86,700 | -51.3% | 0.00% | -50.0% |
| Q2 2023 | $4,135 | -25.7% | 178,100 | -43.5% | 0.01% | -14.3% |
| Q1 2023 | $5,564 | +6.9% | 315,053 | +64.6% | 0.01% | 0.0% |
| Q4 2022 | $5,205 | -99.8% | 191,353 | +36.7% | 0.01% | +133.3% |
| Q3 2022 | $2,418,000 | -17.1% | 140,000 | -16.1% | 0.00% | 0.0% |
| Q2 2022 | $2,918,000 | -18.6% | 166,953 | -20.9% | 0.00% | -25.0% |
| Q1 2022 | $3,584,000 | +183.5% | 211,053 | +352.4% | 0.00% | +100.0% |
| Q4 2021 | $1,264,000 | +44.3% | 46,653 | +103.1% | 0.00% | +100.0% |
| Q4 2020 | $876,000 | +263.5% | 22,975 | +136.9% | 0.00% | – |
| Q2 2020 | $241,000 | +36.9% | 9,700 | -45.2% | 0.00% | – |
| Q1 2020 | $176,000 | -70.5% | 17,700 | -57.3% | 0.00% | – |
| Q4 2019 | $596,000 | – | 41,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |